L
Lawrence Corey
Researcher at New York Medical College
Publications - 169
Citations - 16226
Lawrence Corey is an academic researcher from New York Medical College. The author has contributed to research in topics: Herpes simplex virus & Virus. The author has an hindex of 60, co-authored 169 publications receiving 14342 citations.
Papers
More filters
Journal ArticleDOI
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R. Baden,Hana M. El Sahly,Brandon Essink,Karen L. Kotloff,Sharon E. Frey,Rick Novak,David Diemert,Stephen A. Spector,Nadine Rouphael,C. Buddy Creech,John W McGettigan,Shishir Khetan,Nathan Segall,Joel Solis,Adam Brosz,Carlos Fierro,Howard J. Schwartz,Kathleen M. Neuzil,Lawrence Corey,Peter B. Gilbert,Holly Janes,Dean Follmann,Mary A. Marovich,John R. Mascola,Laura Polakowski,Julie E. Ledgerwood,Barney S. Graham,Hamilton Bennett,Rolando Pajon,Conor Knightly,Brett Leav,Weiping Deng,Honghong Zhou,Shu Liang Han,Melanie Ivarsson,Jacqueline Miller,Tal Z Zaks +36 more
TL;DR: The mRNA-1273 vaccine as discussed by the authors is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19.
Journal ArticleDOI
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Jerald C. Sadoff,Glenda Gray,An Vandebosch,Vicky Cardenas,Georgi Shukarev,Beatriz Grinsztejn,Paul A. Goepfert,Carla Truyers,Hein Fennema,Bart Spiessens,Kim Offergeld,Gert Scheper,Kimberly L Taylor,Merlin L. Robb,John J. Treanor,Dan H. Barouch,Jeffrey J. Stoddard,Martin Ryser,Mary A. Marovich,Kathleen M. Neuzil,Lawrence Corey,Nancy Cauwenberghs,Tamzin Tanner,Karin Hardt,Javier Ruiz-Guiñazú,Mathieu Le Gars,Hanneke Schuitemaker,Johan Van Hoof,Frank Struyf,Macaya Douoguih +29 more
TL;DR: A single dose of Ad26.COV2.S protected against symptomatic Covid-19 and asymptomatic SARS-CoV-2 infection and was effective against severe–critical disease, including hospitalization and death, in an international, randomized, double-blind, placebo-controlled, phase 3 trial.
Journal ArticleDOI
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.
Kieren A. Marr,Fulvio Crippa,Wendy M. Leisenring,Maggie Hoyle,Michael Boeckh,S. Arunmozhi Balajee,W. Garrett Nichols,Benjamin Musher,Lawrence Corey +8 more
TL;DR: Itraconazole appears to prevent invasive mold infections (IMIs) in the subset of patients who tolerate the drug; however, toxicities and poor tolerability limit its success as prophylactic therapy.
Journal ArticleDOI
Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
Richard J. Whitley,Ann M. Arvin,Charles G. Prober,Lawrence Corey,Sandra K. Burchett,Stanley A. Plotkin,Stuart E. Starr,Richard F. Jacobs,Dwight A. Powell,Andre J. Nahmias +9 more
TL;DR: With HSV infection limited to the skin, eyes, or mouth, the presence of three or more recurrences of vesicles was associated with an increased risk of neurologic impairment as compared with two or fewer recurrence.
Journal ArticleDOI
Improved outcome in central nervous system aspergillosis, using voriconazole treatment.
Stefan Schwartz,Markus Ruhnke,Patricia Ribaud,Lawrence Corey,Timothy A. Driscoll,Oliver A. Cornely,Ulrich Schuler,Irja Lutsar,Peter F. Troke,Eckhard Thiel +9 more
TL;DR: It is concluded from this large cohort of patients that voriconazole treatment together with neurosurgical management, whenever feasible, is currently the best approach to treat patients with CNS aspergillosis.